Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study

Treatment of head and neck squamous cell carcinoma (HNSCC) has a detrimental impact on patient quality of life. The rate of recognized distress/depression among HNSCC patients ranges from 9.8% to 83.8%, and the estimated prevalence of depression among patients receiving radiotherapy is 63%. Shorter...

Full description

Bibliographic Details
Main Authors: Łukasz Boguszewicz, Alicja Heyda, Mateusz Ciszek, Agata Bieleń, Agnieszka Skorupa, Jolanta Mrochem-Kwarciak, Krzysztof Składowski, Maria Sokół
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/14/1/60
_version_ 1827369526505766912
author Łukasz Boguszewicz
Alicja Heyda
Mateusz Ciszek
Agata Bieleń
Agnieszka Skorupa
Jolanta Mrochem-Kwarciak
Krzysztof Składowski
Maria Sokół
author_facet Łukasz Boguszewicz
Alicja Heyda
Mateusz Ciszek
Agata Bieleń
Agnieszka Skorupa
Jolanta Mrochem-Kwarciak
Krzysztof Składowski
Maria Sokół
author_sort Łukasz Boguszewicz
collection DOAJ
description Treatment of head and neck squamous cell carcinoma (HNSCC) has a detrimental impact on patient quality of life. The rate of recognized distress/depression among HNSCC patients ranges from 9.8% to 83.8%, and the estimated prevalence of depression among patients receiving radiotherapy is 63%. Shorter overall survival also occurs in preexisting depression or depressive conditions. The present study analyzes the nuclear magnetic resonance (NMR) blood serum metabolic profiles during radio-/chemoradiotherapy and correlates the detected alterations with pain and/or distress accumulated with the disease and its treatment. NMR spectra were acquired on a Bruker 400 MHz spectrometer and analyzed using multivariate methods. The results indicate that distress and/or pain primarily affect the serum lipids and metabolites of energy (glutamine, glucose, lactate, acetate) and one-carbon (glycine, choline, betaine, methanol, threonine, serine, histidine, formate) metabolism. Sparse disturbances in the branched-chain amino acids (BCAA) and in the metabolites involved in protein metabolism (lysine, tyrosine, phenylalanine) are also observed. Depending on the treatment modality—radiotherapy or concurrent chemoradiotherapy—there are some differences in the altered metabolites.
first_indexed 2024-03-08T09:50:42Z
format Article
id doaj.art-360bb6cf8a1d45ecaf6dc96b24043e05
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-08T09:50:42Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-360bb6cf8a1d45ecaf6dc96b24043e052024-01-29T14:05:07ZengMDPI AGMetabolites2218-19892024-01-011416010.3390/metabo14010060Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary StudyŁukasz Boguszewicz0Alicja Heyda1Mateusz Ciszek2Agata Bieleń3Agnieszka Skorupa4Jolanta Mrochem-Kwarciak5Krzysztof Składowski6Maria Sokół7Department of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, PolandDepartment of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, PolandDepartment of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, PolandAnalytics and Clinical Biochemistry Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, PolandDepartment of Medical Physics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, PolandTreatment of head and neck squamous cell carcinoma (HNSCC) has a detrimental impact on patient quality of life. The rate of recognized distress/depression among HNSCC patients ranges from 9.8% to 83.8%, and the estimated prevalence of depression among patients receiving radiotherapy is 63%. Shorter overall survival also occurs in preexisting depression or depressive conditions. The present study analyzes the nuclear magnetic resonance (NMR) blood serum metabolic profiles during radio-/chemoradiotherapy and correlates the detected alterations with pain and/or distress accumulated with the disease and its treatment. NMR spectra were acquired on a Bruker 400 MHz spectrometer and analyzed using multivariate methods. The results indicate that distress and/or pain primarily affect the serum lipids and metabolites of energy (glutamine, glucose, lactate, acetate) and one-carbon (glycine, choline, betaine, methanol, threonine, serine, histidine, formate) metabolism. Sparse disturbances in the branched-chain amino acids (BCAA) and in the metabolites involved in protein metabolism (lysine, tyrosine, phenylalanine) are also observed. Depending on the treatment modality—radiotherapy or concurrent chemoradiotherapy—there are some differences in the altered metabolites.https://www.mdpi.com/2218-1989/14/1/60HNSCCradiotherapychemotherapydistresspainmetabolomics
spellingShingle Łukasz Boguszewicz
Alicja Heyda
Mateusz Ciszek
Agata Bieleń
Agnieszka Skorupa
Jolanta Mrochem-Kwarciak
Krzysztof Składowski
Maria Sokół
Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study
Metabolites
HNSCC
radiotherapy
chemotherapy
distress
pain
metabolomics
title Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study
title_full Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study
title_fullStr Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study
title_full_unstemmed Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study
title_short Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics—A Preliminary Study
title_sort metabolite biomarkers of prolonged and intensified pain and distress in head and neck cancer patients undergoing radio or chemoradiotherapy by means of nmr based metabolomics a preliminary study
topic HNSCC
radiotherapy
chemotherapy
distress
pain
metabolomics
url https://www.mdpi.com/2218-1989/14/1/60
work_keys_str_mv AT łukaszboguszewicz metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy
AT alicjaheyda metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy
AT mateuszciszek metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy
AT agatabielen metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy
AT agnieszkaskorupa metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy
AT jolantamrochemkwarciak metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy
AT krzysztofskładowski metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy
AT mariasokoł metabolitebiomarkersofprolongedandintensifiedpainanddistressinheadandneckcancerpatientsundergoingradioorchemoradiotherapybymeansofnmrbasedmetabolomicsapreliminarystudy